News Psychemedics Corporation

Equities

PMD

US7443752057

Delayed Nasdaq Other stock markets 09:30:00 2024-04-18 am EDT			5-day change	1st Jan Change
2.56 ^USD	+0.79%		-9.22%	-13.51%

Mar. 28	Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	North American Morning Briefing : Tech in Focus on -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Psychemedics Corporation Reports 2023 Financial Results	Mar. 28	GL
North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider	Mar. 21	GL
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider	Mar. 21	AQ
North American Morning Briefing : Investors -2-	Mar. 18	DJ
Psychemedics Corporation Announces Relocation of its Corporate Headquarters to Dallas, Texas	Jan. 02	CI
Psychemedics Relocates Headquarters to Dallas; Shares Rise	Jan. 02	MT
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas	Jan. 02	GL
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance	Nov. 27	GL
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance	Nov. 27	AQ
Tranche Update on Psychemedics Corporation's Equity Buyback Plan announced on March 18, 2008.	Nov. 13	CI
Psychemedics: Q3 Earnings Snapshot	Nov. 09	AQ
Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Posts Q3 Revenue $5.7M	Nov. 09	MT
Psychemedics Corporation Reports Third Quarter 2023 Financial Results	Nov. 09	AQ
Psychemedics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen	23-10-27	GL
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer	23-09-21	CI
Psychemedics Names Chief Revenue Officer	23-09-21	MT
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer	23-09-21	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Psychemedics Corporation

Equities

PMD

US7443752057

Summary

Filters